Albany Molecular Research appoints new COO and head of corporate business development

Contract research and manufacturing organization Albany Molecular Research (Nasdaq: AMRI) has named George Svokos chief operating officer, and Lori Henderson head of corporate business development.

Mr Svokos joined AMRI in January 2014 from Teva Pharmaceutical Industries (NYSE: TEVA), where he was senior vice president of US Technical Operations. Ms Henderson joined the company in February 2011 from technology company Rand Worldwide.

William Marth, president and chief executive of AMRI, said: "Aligning our leadership as we grow and move forward with our strategy to be the preeminent supplier of custom and complex end-to-end services to the pharmaceutical industry will ensure AMRI's success as a whole. Both George and Lori have made significant contributions to AMRI, each demonstrating a leadership and vision, while helping navigate the complex M&A environment as the company continues to expand organically and inorganically."